参考文献/References:
[1]Von Minckwitz G,Huang CS,Mano MS,et al.Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer[J].New England Journal of Medicine,2019,380(7):617-628. [2]Yanes T,Young MA,Meiser B,et al.Clinical applications of polygenic breast cancer risk:a critical review and perspectives of an emerging field[J].Breast Cancer Research,2020,22(1):10. [3]Collaborative Group on Hormonal Factors in Breast Cancer.Type and timing of menopausal hormone therapy and breast cancer risk:individual participant meta-analysis of the worldwide epidemiological evidence[J].Lancet,2019,394(10204):1159-1168. [4]Andre F,Ciruelos E,Rubovszky G,et al.Alpelisib for PIK3CA-Mutated,Hormone Receptor-Positive Advanced Breast Cancer[J].New England Journal of Medicine,2019,380(20):1929-1940. [5]姚颖,吴承玉.体质与乳腺癌的相关性研究[J].中国临床研究,2015,28(4):517-519. [6]Robson M,Im SA,Senkus E,et al.Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation[J].New England Journal of Medicine,2017,377(6):523-533. [7]Bertucci F,Ng CKY,Patsouris A,et al.Genomic characterization of metastatic breast cancers[J].Nature,2019,569(7757):560-564. [8]Cheng FF,Su L,Yao C,et al.SIRT1 promotes epithelial-mesenchymal transition and metastasis in colorectal cancer by regulating Fra-1 expression[J].Cancer Letters,2016,375(2):274-283. [9]Buhrmann C,Shayan P,Popper B,et al.Sirt1 Is Required for Resveratrol-Mediated Chemopreventive Effects in Colorectal Cancer Cells[J].Nutrients,2016,8(3):21. [10]Lee YH,Song NY,Suh J,et al.Curcumin suppresses oncogenicity of human colon cancer cells by covalently modifying the cysteine 67 residue of SIRT1[J].Cancer Letters,2018(431):219-229. [11]So D,Shin HW,Kim J,et al.Cervical cancer is addicted to SIRT1 disarming the AIM2 antiviral defense[J].Oncogene,2018,37(38):5191-5204. [12]Ferrer CM,Lu TY,Bacigalupa ZA,et al.O-GlcNAcylation regulates breast cancer metastasis via SIRT1 modulation of FOXM1 pathway[J].Oncogene,2017,36(4):559-569. [13]Campochiaro PA,Lauer AK,Sohn EH,et al.Lentiviral Vector Gene Transfer of Endostatin/Angiostatin for Macular Degeneration(GEM)Study[J].Human Gene Therapy,2017,28(1):99-111. [14]Igci M,Kalender ME,Borazan E,et al.High-throughput screening of Sirtuin family of genes in breast cancer[J].Gene,2016,586(1):123-128. [15]Doering CB,Denning G,Shields JE,et al.Preclinical Development of a Hematopoietic Stem and Progenitor Cell Bioengineered Factor VIII Lentiviral Vector Gene Therapy for Hemophilia A[J].Human Gene Therapy,2018,29(10):1183-1201. [16]Charrier S,Lagresle-Peyrou C,Poletti V,et al.Biosafety Studies of a Clinically Applicable Lentiviral Vector for the Gene Therapy of Artemis-SCID[J].Molecular Therapy Methods&Clinical Development,2019(15):232-245. [17]Farinelli G,Hernandez RJ,Rossi A,et al.Lentiviral Vector Gene Therapy Protects XCGD Mice From Acute Staphylococcus aureus Pneumonia and Inflammatory Response[J].Molecular Therapy,2016,24(10):1873-1880. [18]Estiri H,Fallah A,Soleimani M,et al.Stable Knockdown of Adenosine Kinase by Lentiviral Anti-ADK miR-shRNAs in Wharton’s Jelly Stem Cells[J].Cell J,2018,20(1):1-9. [19]Shimizu S,Yadav SS,An DS.Stable Delivery of CCR5-Directed shRNA into Human Primary Peripheral Blood Mononuclear Cells and Hematopoietic Stem/Progenitor Cells via a Lentiviral Vector[J].Methods in Molecular Biology(Clifton,NJ),2016(1364):235-248. [20]Mcandrews KM,Lebleu VS,Kalluri R.SIRT1 Regulates Lysosome Function and Exosome Secretion[J].Developmental Cell,2019,49(3):302-303. [21]Kulkarni CA,Milliken AS,Brookes PS.Role of Acidic pH in Linking SIRT1 and Cardioprotective Metabolism[J].Circulation Research,2019(125):1. [22]Foteinou PT,Venkataraman A,Francey LJ,et al.Computational and experimental insights into the circadian effects of SIRT1[J].Proceedings of the National Academy of Sciences of the United States of America,2018,115(45):11643-11648. [23]Chen XJ,Huan HB,Liu CG,et al.Deacetylation of beta-catenin by SIRT1 regulates self-renewal and oncogenesis of liver cancer stem cells[J].Cancer Letters2019(463):1-10. [24]田舍,江建新,喻超,等.SIRT1通过调节FOXO1/RAB7信号通路促进低氧诱导的胰腺癌细胞自噬[J].中国病理生理杂志,2019,35(9):1545-1550. [25]林治华,王俊伟,邓雅庭,等.SIRT1与肝细胞癌病理及预后的研究进展及靶向治疗展望[J].重庆理工大学学报:自然科学,2019,33(7):221-227. [26]臧宇,傅恩清.同步放化疗联合甘氨双唑钠治疗难治性非小细胞肺癌的疗效及对microRNA-21和SIRT1表达的影响[J].中国肿瘤临床与康复,2019,26(8):7-10. [27]Wu SH,Tang SY,Peng HS,et al.Effects of lentivirus-mediated CCR3 RNA interference on the function of mast cells of allergic rhinitis in mice[J].International Immunopharmacology,2020(78):9. [28]He SX,Wang ZH,Tang H,et al.MiR-217 Inhibits Proliferation,Migration,and Invasion by Targeting SIRT1 in Osteosarcoma[J].Cancer Biotherapy and Radiopharmaceuticals,2019,34(4):264-270. [29]Liu H,Liu N,Zhao Y,et al.Oncogenic USP22 supports gastric cancer growth and metastasis by activating c-Myc/NAMPT/SIRT1-dependent FOXO1 and YAP signaling[J].Aging(Albany NY),2019,11(21):9643-9660. [30]Qi HF,Wang HF,Pang DB.miR-448 promotes progression of non-small-cell lung cancer via targeting SIRT1[J].Experimental and Therapeutic Medicine,2019,18(3):1907-1913.